C
Carlo Bastianelli
Researcher at Sapienza University of Rome
Publications - 53
Citations - 1129
Carlo Bastianelli is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Population & Family planning. The author has an hindex of 20, co-authored 52 publications receiving 986 citations. Previous affiliations of Carlo Bastianelli include Policlinico Umberto I.
Papers
More filters
Journal ArticleDOI
Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 μg of ethinyl estradiol and 3 mg of drospirenone
Hans-Joachim Ahrendt,Israel Nisand,Carlo Bastianelli,María Ángeles Gómez,Kristina Gemzell-Danielsson,Wolfgang Urdl,Birgit Karskov,Luc Oeyen,Johannes Bitzer,Geert Page,Ian Milsom +10 more
TL;DR: NuvaRing has comparable efficacy and tolerability to a COC containing 30 microg of EE and 3 mg drospirenone, and user acceptability of both methods was high.
Journal ArticleDOI
Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone.
Ian Milsom,I Lete,A Bjertnaes,K Rokstad,Ingela Lindh,C J Gruber,Martin Birkhäuser,E Aubeny,T Knudsen,Carlo Bastianelli +9 more
TL;DR: NuvaRing was associated with better cycle control than the COC, and there was no clinically relevant difference between the two groups in bodyweight.
Journal ArticleDOI
Cholangiocarcinoma: increasing burden of classifications.
Vincenzo Cardinale,Maria Consiglia Bragazzi,Guido Carpino,A. Torrice,A. Fraveto,Raffaele Gentile,Vincenzo Pasqualino,Fabio Melandro,Camilla Aliberti,Carlo Bastianelli,Roberto Brunelli,Pasquale Berloco,Eugenio Gaudio,Domenico Alvaro +13 more
TL;DR: The different proposed classifications of CCA are discussed in relation with recent advances in pathophysiology and biology of this cancer.
Journal ArticleDOI
A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: II. The comparison of bleeding patterns
Task Force on Long-Acting Systemic Agents for Fertility Regulation,S. Said,W. Sadek,A. Kholeif,Suporn Koetsawang,Orawan Kiriwat,Surat Piboonmanee,Roberto Rivera,Gloria Alvarado,M. A. Juarez,S. Aquilar,R. Santiso,C.F. Contreras,L.F. Galichl,M. Guirola,M.G. Alzugaray,M.L. Hernandez,J.R. Gallarco,Biran Affandi,S. S I Santoso,R. S. Samil,A. Kazi,E.S. Kononova,V.I. Alipov,Ruben Apelo,E.S. Bernardo,I. Benitez,T. Canto-de-Cetina,S. Cardenas,L.E. Polanco,L. Vera,M.C. Cravioto,L. Hernandez,J.L. Fuziwara,J. Garza-Flores,G. Perez-Palacios,G. Oropeza,E. Mota,E. Zavaleta,Giuseppe Benagiano,Carlo Bastianelli,A. Diaz Infante-Ibarra,C.J. Castelo,R. Jiminez,N. Perez-Arocha,J. Lang-Prieto,J.A. Casas-Fernandez,H.M. Perez-Paz,María Honrubia Pérez,A.R. Hernandez,C.Bustillo Tur,L. Kovacs,S. Koloszar,Susana Bassol,A.M. Trujillo,Rene Guzman-Serani,E. Israel,Catherine d'Arcangues,B. Busca,P.E. Hall,D. Machin,A. Pinol,F. Schlagenhaft +62 more
TL;DR: The analysis suggests how the life-table analysis of discontinuation reasons underestimates the true incidence of vaginal bleeding irregularities in a clinical trial.
Journal ArticleDOI
Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis
Vincenzo Cardinale,Guido Carpino,Raffaele Gentile,Chiara Napoletano,Hassan Rahimi,Antonio Franchitto,Rossella Semeraro,Marianna Nuti,Paolo Onori,Pasquale Berloco,Massimo Rossi,Daniela Bosco,Roberto Brunelli,A. Fraveto,Cristina Napoli,A. Torrice,M. Gatto,Rosanna Venere,Carlo Bastianelli,Camilla Aliberti,Filippo Maria Salvatori,Luciano Bresadola,Mario Bezzi,Adolfo Francesco Attili,Lola M. Reid,Eugenio Gaudio,Domenico Alvaro +26 more
TL;DR: This report represents proof of the concept that the human fetal biliary tree stem cells are a suitable and large source for cell therapy of liver cirrhosis and represents the basis for forthcoming controlled clinical trials.